(HAS) Hasbro - Overview
Stock: Toys, Games, Collectibles, Entertainment, Licensing
| Risk 5d forecast | |
|---|---|
| Volatility | 29.9% |
| Relative Tail Risk | -13.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.32 |
| Alpha | 36.26 |
| Character TTM | |
|---|---|
| Beta | 1.008 |
| Beta Downside | 0.875 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.27% |
| CAGR/Max DD | 0.80 |
EPS (Earnings per Share)
Revenue
Description: HAS Hasbro March 05, 2026
Hasbro, Inc. is a global toy and game company. It operates in North America, Europe, Latin America, Australia, and Asia.
The companys product portfolio includes trading cards, action figures, dolls, and preschool toys. It also offers licensed products like apparel and publishing goods. The toy and game sector is characterized by strong brand recognition and intellectual property licensing.
Hasbro sources, markets, and sells toy and game products. It promotes brands through out-licensing trademarks and intellectual property for consumer products. The company also develops and licenses digital game experiences based on its brands. This business model leverages intellectual property across multiple entertainment formats.
Additionally, Hasbro develops and produces branded entertainment content, including film, television, and digital content. Distribution channels include various retailers, wholesalers, and e-commerce platforms. Key brands include MAGIC: THE GATHERING, TRANSFORMERS, DUNGEONS & DRAGONS, and NERF, alongside licensed brands such as STAR WARS and SPIDER-MAN. For deeper insights into Hasbros financial performance and market position, consider exploring further research on ValueRay.
Headlines to watch out for
- Toy and game sales drive core revenue growth
- Digital gaming and entertainment content expands revenue streams
- Licensing agreements for popular brands boost intellectual property income
- Supply chain disruptions and raw material costs impact profitability
- Consumer discretionary spending trends influence toy demand
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: -322.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 4.70 > 1.0 |
| NWC/Revenue: 15.16% < 20% (prev 20.34%; Δ -5.18% < -1%) |
| CFO/TA 0.16 > 3% & CFO 893.2m > Net Income -322.4m |
| Net Debt (2.49b) to EBITDA (232.7m): 10.69 < 3 |
| Current Ratio: 1.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (142.6m) vs 12m ago 2.15% < -2% |
| Gross Margin: 70.26% > 18% (prev 0.65%; Δ 6962 % > 0.5%) |
| Asset Turnover: 79.06% > 50% (prev 65.23%; Δ 13.84% > 0%) |
| Interest Coverage Ratio: 0.38 > 6 (EBITDA TTM 232.7m / Interest Expense TTM 163.4m) |
Altman Z'' 2.13
| A: 0.13 (Total Current Assets 2.58b - Total Current Liabilities 1.87b) / Total Assets 5.55b |
| B: 0.28 (Retained Earnings 1.55b / Total Assets 5.55b) |
| C: 0.01 (EBIT TTM 61.4m / Avg Total Assets 5.95b) |
| D: 0.29 (Book Value of Equity 1.45b / Total Liabilities 4.99b) |
| Altman-Z'' Score: 2.13 = BBB |
Beneish M -3.32
| DSRI: 1.01 (Receivables 1.06b/919.8m, Revenue 4.70b/4.14b) |
| GMI: 0.92 (GM 70.26% / 64.61%) |
| AQI: 0.82 (AQ_t 0.49 / AQ_t-1 0.60) |
| SGI: 1.14 (Revenue 4.70b / 4.14b) |
| TATA: -0.22 (NI -322.4m - CFO 893.2m) / TA 5.55b) |
| Beneish M-Score: -3.32 (Cap -4..+1) = AA |
What is the price of HAS shares?
Over the past week, the price has changed by -3.30%, over one month by -0.33%, over three months by +20.76% and over the past year by +55.19%.
Is HAS a buy, sell or hold?
- StrongBuy: 7
- Buy: 5
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HAS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 114.5 | 19.5% |
| Analysts Target Price | 114.5 | 19.5% |
HAS Fundamental Data Overview March 07, 2026
P/S = 2.8539
P/B = 24.9159
P/EG = 2.514
Revenue TTM = 4.70b USD
EBIT TTM = 61.4m USD
EBITDA TTM = 232.7m USD
Long Term Debt = 2.77b USD (from longTermDebt, last quarter)
Short Term Debt = 497.0m USD (from shortTermDebt, last quarter)
Debt = 3.26b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.49b USD (from netDebt column, last quarter)
Enterprise Value = 15.80b USD (13.42b + Debt 3.26b - CCE 882.0m)
Interest Coverage Ratio = 0.38 (Ebit TTM 61.4m / Interest Expense TTM 163.4m)
EV/FCF = 19.04x (Enterprise Value 15.80b / FCF TTM 829.9m)
FCF Yield = 5.25% (FCF TTM 829.9m / Enterprise Value 15.80b)
FCF Margin = 17.65% (FCF TTM 829.9m / Revenue TTM 4.70b)
Net Margin = -6.86% (Net Income TTM -322.4m / Revenue TTM 4.70b)
Gross Margin = 70.26% ((Revenue TTM 4.70b - Cost of Revenue TTM 1.40b) / Revenue TTM)
Gross Margin QoQ = 68.95% (prev 68.37%)
Tobins Q-Ratio = 2.85 (Enterprise Value 15.80b / Total Assets 5.55b)
Interest Expense / Debt = 1.24% (Interest Expense 40.4m / Debt 3.26b)
Taxrate = 25.03% (67.8m / 270.9m)
NOPAT = 46.0m (EBIT 61.4m * (1 - 25.03%))
Current Ratio = 1.38 (Total Current Assets 2.58b / Total Current Liabilities 1.87b)
Debt / Equity = 6.06 (Debt 3.26b / totalStockholderEquity, last quarter 538.5m)
Debt / EBITDA = 10.69 (Net Debt 2.49b / EBITDA 232.7m)
Debt / FCF = 3.00 (Net Debt 2.49b / FCF TTM 829.9m)
Total Stockholder Equity = 589.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -5.42% (Net Income -322.4m / Total Assets 5.55b)
RoE = -54.74% (Net Income TTM -322.4m / Total Stockholder Equity 589.0m)
RoCE = 1.83% (EBIT 61.4m / Capital Employed (Equity 589.0m + L.T.Debt 2.77b))
RoIC = 1.18% (NOPAT 46.0m / Invested Capital 3.90b)
WACC = 7.93% (E(13.42b)/V(16.68b) * Re(9.63%) + D(3.26b)/V(16.68b) * Rd(1.24%) * (1-Tc(0.25)))
Discount Rate = 9.63% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.25%
[DCF] Terminal Value 80.09% ; FCFF base≈757.9m ; Y1≈859.7m ; Y5≈1.17b
[DCF] Fair Price = 127.6 (EV 20.44b - Net Debt 2.49b = Equity 17.95b / Shares 140.7m; r=7.93% [WACC]; 5y FCF grow 15.67% → 2.90% )
EPS Correlation: 27.43 | EPS CAGR: 29.67% | SUE: 2.07 | # QB: 1
Revenue Correlation: -26.71 | Revenue CAGR: 5.98% | SUE: 2.88 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.30 | Chg7d=+0.010 | Chg30d=+0.019 | Revisions Net=+0 | Analysts=11
EPS current Year (2026-12-31): EPS=5.68 | Chg7d=+0.029 | Chg30d=+0.385 | Revisions Net=+11 | Growth EPS=+2.5% | Growth Revenue=+4.4%
EPS next Year (2027-12-31): EPS=6.27 | Chg7d=+0.035 | Chg30d=+0.448 | Revisions Net=+7 | Growth EPS=+10.4% | Growth Revenue=+6.8%
[Analyst] Revisions Ratio: +0.00 (2 Up / 2 Down within 30d for Next Quarter)